BIO-TECHNE Corp 4

4 · BIO-TECHNE Corp · Filed Aug 11, 2015

Form 4

Period: 2015-08-07

VP-Hematology Operations

Transactions

Award
Restricted Stock Units
2015-08-07+600→ 600 total
→ Common Stock (600 underlying)
Award
Stock Option (Right to Buy)
2015-08-07+3,750→ 3,750 total
Exercise: $108.49Exp: 2022-08-07→ Common Stock (3,750 underlying)
Award
Stock Option (Right to Buy)
2015-08-07+7,500→ 7,500 total
Exercise: $108.49Exp: 2022-08-07→ Common Stock (7,500 underlying)

Holdings

Stock Option (Right to Buy)
Exercise: $76.15Exp: 2018-07-27→ Common Stock (20,000 underlying)
20,000
Stock Option (Right to Buy)
Exercise: $76.02Exp: 2020-07-31→ Common Stock (15,000 underlying)
15,000
Common Stock
(indirect: by Stock Bonus Plan)
6,827
Stock Option (Right to Buy)
Exercise: $62.46Exp: 2016-07-23→ Common Stock (494 underlying)
494
Stock Option (Right to Buy)
Exercise: $76.15Exp: 2018-08-27→ Common Stock (1,129 underlying)
1,129
Stock Option (Right to Buy)
Exercise: $66.25Exp: 2017-04-29→ Common Stock (10,000 underlying)
10,000
Stock Option (Right to Buy)
Exercise: $74.05Exp: 2019-07-26→ Common Stock (1,097 underlying)
1,097
Common Stock
34,913
Stock Option (Right to Buy)
Exercise: $58.40Exp: 2017-07-29→ Common Stock (1,281 underlying)
1,281
Stock Option (Right to Buy)
Exercise: $94.35Exp: 2021-08-12→ Common Stock (15,000 underlying)
15,000

Footnotes (6)

[F1]Fully exercisable.
[F2]Vests 3,750 shares on each of 8/1/14, 8/1/15, 8/1/16, and 8/1/17.
[F3]Vests 3,750 shares on each of 8/12/15, 8/12/16, 8/12/17, and 8/12/18.
[F4]Vests 1,875 shares on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
[F5]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
[F6]Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years.

Documents

2 files